Drug Database
Back to search

United Kingdom· GB-APID-32047111000001105

Cleviprex 25mg/50ml emulsion for infusion vials

A clevidipine product containing clevidipine, registered in United Kingdom by Chiesi Ltd. The same ATC class is registered in 8 of our 19 countries.

ATC C08CA16

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedCleviprex 25mg/50ml emulsion for infu…ATCC08CA16REGISTER NO.GB-APID-3204711100000…PACKS LISTED2CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about clevidipineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Clevidipine is registered in 8 of 19 countries.

Countries holding a registration under ATC C08CA16 (clevidipine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 4 of them publish a price we can compare per daily dose
Search clevidipine products by name

Clevidipine · ATC C08CA16

8 / 19 countries

  • Belgiumprice
  • Canada
  • Franceprice
  • Germany
  • Netherlands
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Clevidipine
Manufacturer
Chiesi Ltd
Country
United Kingdom (GB)
ATC code
C08CA16
ATC class
Clevidipine
Defined daily dose
0.12 g, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    5060185120035
  • gtin
    05060185120035

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

92 interactions on record for clevidipine.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check clevidipine against other medicinesHow interaction checks work

Clevidipine · interactions on record

92 records

  • 5 severe
  • 85 moderate
  • 1 minor

Most severe, free to view

  • DolasetronA04AA04severe
  • CeritinibL01ED02severe
  • CeritinibL01XE28severe
  • SiponimodL04AA42severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Clevidipine in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All clevidipine products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Austria · Cleviprex
  • Belgium · Cleviprex
  • Germany · Cleviprex
  • Spain · Cleviprex
  • France · Cleviprex
  • Italy · Cleviprex
  • Luxembourg · Cleviprex
  • Netherlands · Cleviprex
  • Sweden · Cleviprex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0c47524d-7597-49a9-af82-0ee8ad05211d
GET /v1/drugs/0c47524d-7597-49a9-af82-0ee8ad05211d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "32047111000001105",
  "desc": "Cleviprex 25mg/50ml emulsion for infusion vials (Chiesi Ltd)",
  "form": "Emulsion for infusion",
  "vpid": "32046911000001105",
  "source": "dmd",
  "vtm_id": "775284002",
  "strength": "500 microgram",
  "substance": "Clevidipine",
  "ingredient": "Clevidipine",
  "supplier_code": "9052511000001105"
}
API referenceMCP serverPlans

See everything about clevidipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console